Prevalence and risk factors for latent tuberculosis infection among household contacts of index cases in two South African provinces: Analysis of baseline data from a cluster-randomised trial.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 25 10 2019
accepted: 26 02 2020
entrez: 18 3 2020
pubmed: 18 3 2020
medline: 27 6 2020
Statut: epublish

Résumé

Household contacts of patients with active pulmonary tuberculosis (TB) often have latent TB infection, and are at risk of progression to disease. We set out to investigate whether index TB case HIV status was linked to a higher probability of latent TB infection among household contacts. Data were collected prospectively from participants in the intervention arm of a household cluster-randomised trial in two South Africa provinces (Mangaung, Free State, and Capricorn, Limpopo). In intervention group households, TB contacts underwent HIV testing and tuberculin skin testing (TST). TST induration was estimated at two cut-offs (≥5mm, ≥10mm). Multilevel Bayesian regression models estimated posterior distributions of the percentage of household contacts with TST induration ≥5mm and ≥10mm by age group, and compared the odds of latent TB infection by key risk factors including HIV status index case age and study province. A total of 2,985 household contacts of 924 index cases were assessed, with most 2,725 (91.3%) undergoing TST. HIV prevalence in household contacts was 14% and 10% in Mangaung and Capricorn respectively. Overall, 16.8% (458/2,725) had TST induration of ≥5mm and 13.1% (359/2,725) ≥10mm. In Mangaung, children aged 0-4 years had a high TST positivity prevalence compared to their peers in Capricorn (22.0% vs. 7.6%, and 20.5% vs. 2.3%, using TST thresholds of ≥5mm and ≥10mm respectively). Compared to contacts from Capricorn, household contacts living in Mangaung were more likely to have TST induration ≥5mm (odds ratio [OR]: 3.08, 95% credibility interval [CI]: 2.13-4.58) and ≥10mm (OR: 4.52, 95% CI: 3.03-6.97). There was a 90% and 92% posterior probability that the odds of TST induration ≥5mm (OR: 0.79, 95% CI: 0.56-1.14) and ≥10mm (OR: 0.77, 95% CI: 0.53-1.10) respectively were lower in household contacts of HIV-positive compared to HIV-negative index cases. High TST induration positivity, especially among young children and people living in Mangaung indicates considerable TB transmission despite high antiretroviral therapy coverage. Household contact of HIV-positive index TB cases were less likely to have evidence of latent TB infection than contacts of HIV-negative index cases.

Identifiants

pubmed: 32182274
doi: 10.1371/journal.pone.0230376
pii: PONE-D-19-29656
pmc: PMC7077873
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0230376

Subventions

Organisme : Medical Research Council
ID : MR/R010161/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT089673
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist

Références

Int J Tuberc Lung Dis. 2010 Apr;14(4):406-12
pubmed: 20202297
PLoS Med. 2016 Oct 25;13(10):e1002152
pubmed: 27780211
Lancet. 2015 Dec 5;386(10010):2344-53
pubmed: 26515679
N Engl J Med. 1975 Sep 4;293(10):501-2
pubmed: 1152865
PLoS One. 2014 Apr 23;9(4):e95372
pubmed: 24759741
Cochrane Database Syst Rev. 2010 Jan 20;(1):CD000171
pubmed: 20091503
Eur Respir J. 2005 Jan;25(1):181-5
pubmed: 15640340
Lancet Infect Dis. 2016 Feb;16(2):227-38
pubmed: 26867464
Lancet Glob Health. 2017 Nov;5(11):e1048-e1049
pubmed: 29025618
Int J Tuberc Lung Dis. 2015 Nov;19(11):1290-2
pubmed: 26467579
Eur Respir J. 2010 Oct;36(4):925-49
pubmed: 20889463
Eur Respir J. 2013 Jan;41(1):140-56
pubmed: 22936710
Am J Epidemiol. 2017 Jun 15;185(12):1327-1339
pubmed: 28982226
Lancet. 2013 Oct 5;382(9899):1183-94
pubmed: 23915882
PLoS Med. 2019 Apr 23;16(4):e1002787
pubmed: 31013273
N Engl J Med. 2015 May 28;372(22):2127-35
pubmed: 26017823
Lancet Respir Med. 2019 Jun;7(6):544-552
pubmed: 31078497
Cochrane Database Syst Rev. 2017 Aug 29;8:CD006418
pubmed: 28850172
BMC Infect Dis. 2019 Oct 12;19(1):839
pubmed: 31606032
Science. 2013 Feb 22;339(6122):961-5
pubmed: 23430655
Cochrane Database Syst Rev. 2000;(2):CD001363
pubmed: 10796642
Lancet. 2010 May 22;375(9728):1814-29
pubmed: 20488524
Int J Tuberc Lung Dis. 2017 Nov 1;21(11):1147-1154
pubmed: 29037295
Bull World Health Organ. 2019 Jun 1;97(6):405-414
pubmed: 31210678

Auteurs

Peter MacPherson (P)

Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, England, United Kingdom.
Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.

Limakatso Lebina (L)

SA MRC Soweto Matlosana Collaborating Centre for HIV/AIDS and TB, Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Kegaugetswe Motsomi (K)

SA MRC Soweto Matlosana Collaborating Centre for HIV/AIDS and TB, Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Zama Bosch (Z)

SA MRC Soweto Matlosana Collaborating Centre for HIV/AIDS and TB, Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Minja Milovanovic (M)

SA MRC Soweto Matlosana Collaborating Centre for HIV/AIDS and TB, Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Andrew Ratsela (A)

Department of Internal Medicine, University of Limpopo, and Limpopo Department of Health, Polokwane, South Africa.

Sanjay Lala (S)

Department of Paediatrics and Child Health, Chris Hani Baragwanath Academic Hospital and University of the Witwatersrand, Johannesburg, South Africa.

Ebrahim Variava (E)

Department of Internal Medicine, Klerksdorp Tshepong Hospital Complex, North West Department of Health and University of the Witwatersrand, Polokwane, South Africa.

Jonathan E Golub (JE)

Johns Hopkins University Center for TB Research, Baltimore, Maryland, United States of America.

Emily L Webb (EL)

MRC Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, London, England, United Kingdom.

Neil A Martinson (NA)

Department of Paediatrics and Child Health, Chris Hani Baragwanath Academic Hospital and University of the Witwatersrand, Johannesburg, South Africa.
Johns Hopkins University Center for TB Research, Baltimore, Maryland, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH